

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | tricarboxylic acid cycle (GO:0006099) | 5.30729359 |
| 2 | sarcomere organization (GO:0045214) | 5.16356838 |
| 3 | carnitine shuttle (GO:0006853) | 5.07429861 |
| 4 | lysine metabolic process (GO:0006553) | 4.86624508 |
| 5 | lysine catabolic process (GO:0006554) | 4.86624508 |
| 6 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.75547992 |
| 7 | fatty acid transmembrane transport (GO:1902001) | 4.69746799 |
| 8 | 2-oxoglutarate metabolic process (GO:0006103) | 4.54746880 |
| 9 | NADH metabolic process (GO:0006734) | 4.54234914 |
| 10 | fatty acid beta-oxidation (GO:0006635) | 4.25977550 |
| 11 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.25811623 |
| 12 | carnitine transport (GO:0015879) | 4.22613724 |
| 13 | amino-acid betaine transport (GO:0015838) | 4.22613724 |
| 14 | cardiac myofibril assembly (GO:0055003) | 4.20868277 |
| 15 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.19404398 |
| 16 | carnitine transmembrane transport (GO:1902603) | 4.13717884 |
| 17 | plasma membrane repair (GO:0001778) | 4.01674738 |
| 18 | actin-myosin filament sliding (GO:0033275) | 3.94328483 |
| 19 | muscle filament sliding (GO:0030049) | 3.94328483 |
| 20 | aspartate family amino acid catabolic process (GO:0009068) | 3.93970537 |
| 21 | regulation of sequestering of triglyceride (GO:0010889) | 3.91408578 |
| 22 | cardiac muscle contraction (GO:0060048) | 3.89777582 |
| 23 | tricarboxylic acid metabolic process (GO:0072350) | 3.89295801 |
| 24 | fructose metabolic process (GO:0006000) | 3.87860191 |
| 25 | myofibril assembly (GO:0030239) | 3.87745682 |
| 26 | regulation of fatty acid oxidation (GO:0046320) | 3.80916464 |
| 27 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.78495849 |
| 28 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.78463166 |
| 29 | skeletal muscle contraction (GO:0003009) | 3.72766777 |
| 30 | fatty acid oxidation (GO:0019395) | 3.70307075 |
| 31 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.68306901 |
| 32 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.66928072 |
| 33 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.64380239 |
| 34 | lipid oxidation (GO:0034440) | 3.63706551 |
| 35 | regulation of skeletal muscle contraction (GO:0014819) | 3.63020772 |
| 36 | fatty acid catabolic process (GO:0009062) | 3.61845279 |
| 37 | quaternary ammonium group transport (GO:0015697) | 3.55038770 |
| 38 | acetyl-CoA metabolic process (GO:0006084) | 3.48814639 |
| 39 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.46408233 |
| 40 | succinate metabolic process (GO:0006105) | 3.45504887 |
| 41 | short-chain fatty acid metabolic process (GO:0046459) | 3.44419702 |
| 42 | urea cycle (GO:0000050) | 3.42892222 |
| 43 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.41590212 |
| 44 | carnitine metabolic process (GO:0009437) | 3.40977830 |
| 45 | oxaloacetate metabolic process (GO:0006107) | 3.39777701 |
| 46 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.39432271 |
| 47 | valine metabolic process (GO:0006573) | 3.39027449 |
| 48 | cell communication involved in cardiac conduction (GO:0086065) | 3.37233252 |
| 49 | regulation of triglyceride catabolic process (GO:0010896) | 3.34209881 |
| 50 | angiotensin maturation (GO:0002003) | 3.33066835 |
| 51 | regulation of actin filament-based movement (GO:1903115) | 3.32338371 |
| 52 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.30450808 |
| 53 | cellular ketone body metabolic process (GO:0046950) | 3.30202326 |
| 54 | actomyosin structure organization (GO:0031032) | 3.29534197 |
| 55 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.27272788 |
| 56 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.25426505 |
| 57 | cardiac muscle cell development (GO:0055013) | 3.24807789 |
| 58 | actin-mediated cell contraction (GO:0070252) | 3.23664341 |
| 59 | desmosome organization (GO:0002934) | 3.22734358 |
| 60 | positive regulation of fatty acid oxidation (GO:0046321) | 3.21910016 |
| 61 | urea metabolic process (GO:0019627) | 3.21801700 |
| 62 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.21180855 |
| 63 | striated muscle contraction (GO:0006941) | 3.20671366 |
| 64 | amino-acid betaine metabolic process (GO:0006577) | 3.20332397 |
| 65 | creatine metabolic process (GO:0006600) | 3.19374747 |
| 66 | monocarboxylic acid catabolic process (GO:0072329) | 3.18247108 |
| 67 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.15991972 |
| 68 | proline biosynthetic process (GO:0006561) | 3.12105200 |
| 69 | glyoxylate metabolic process (GO:0046487) | 3.12032984 |
| 70 | nitrogen cycle metabolic process (GO:0071941) | 3.05944674 |
| 71 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.04113710 |
| 72 | cardiac cell development (GO:0055006) | 3.03917688 |
| 73 | striated muscle atrophy (GO:0014891) | 3.03306321 |
| 74 | regulation of cofactor metabolic process (GO:0051193) | 3.01187590 |
| 75 | regulation of coenzyme metabolic process (GO:0051196) | 3.01187590 |
| 76 | protein localization to endosome (GO:0036010) | 3.00962821 |
| 77 | biotin metabolic process (GO:0006768) | 3.00876851 |
| 78 | Golgi transport vesicle coating (GO:0048200) | 2.98093539 |
| 79 | COPI coating of Golgi vesicle (GO:0048205) | 2.98093539 |
| 80 | cardiac muscle hypertrophy (GO:0003300) | 2.97139411 |
| 81 | negative regulation of necroptotic process (GO:0060546) | 2.97051034 |
| 82 | regulation of cholesterol homeostasis (GO:2000188) | 2.96884027 |
| 83 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.94755599 |
| 84 | focal adhesion assembly (GO:0048041) | 2.93965634 |
| 85 | cell-substrate adherens junction assembly (GO:0007045) | 2.93965634 |
| 86 | phospholipid homeostasis (GO:0055091) | 2.93915217 |
| 87 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.93333701 |
| 88 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.93280784 |
| 89 | barbed-end actin filament capping (GO:0051016) | 2.92901240 |
| 90 | drug catabolic process (GO:0042737) | 2.90706634 |
| 91 | branched-chain amino acid metabolic process (GO:0009081) | 2.90183355 |
| 92 | flavonoid metabolic process (GO:0009812) | 2.89209814 |
| 93 | regulation of necrotic cell death (GO:0010939) | 2.87981548 |
| 94 | regulation of early endosome to late endosome transport (GO:2000641) | 2.87219442 |
| 95 | apoptotic process involved in morphogenesis (GO:0060561) | 2.86842786 |
| 96 | gluconeogenesis (GO:0006094) | 2.86678393 |
| 97 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.86347036 |
| 98 | sulfur amino acid catabolic process (GO:0000098) | 2.83932087 |
| 99 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.83556226 |
| 100 | striated muscle hypertrophy (GO:0014897) | 2.82436886 |
| 101 | kynurenine metabolic process (GO:0070189) | 2.82194976 |
| 102 | ketone body metabolic process (GO:1902224) | 2.82147245 |
| 103 | cell communication by electrical coupling (GO:0010644) | 2.81966001 |
| 104 | 4-hydroxyproline metabolic process (GO:0019471) | 2.81765589 |
| 105 | positive regulation of lipid catabolic process (GO:0050996) | 2.80679463 |
| 106 | branched-chain amino acid catabolic process (GO:0009083) | 2.80183580 |
| 107 | glucose 6-phosphate metabolic process (GO:0051156) | 2.79763913 |
| 108 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.79538368 |
| 109 | heart trabecula formation (GO:0060347) | 2.79436105 |
| 110 | epithelial cell-cell adhesion (GO:0090136) | 2.78329930 |
| 111 | glycosphingolipid catabolic process (GO:0046479) | 2.77401593 |
| 112 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.75737642 |
| 113 | skeletal muscle adaptation (GO:0043501) | 2.75584065 |
| 114 | regulation of necroptotic process (GO:0060544) | 2.73967435 |
| 115 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.73540487 |
| 116 | pinocytosis (GO:0006907) | 2.73072681 |
| 117 | hexose biosynthetic process (GO:0019319) | 2.72994579 |
| 118 | positive regulation of lipid storage (GO:0010884) | 2.71712470 |
| 119 | cysteine metabolic process (GO:0006534) | 2.71510165 |
| 120 | monosaccharide biosynthetic process (GO:0046364) | 2.70524572 |
| 121 | response to mercury ion (GO:0046689) | 2.70493222 |
| 122 | low-density lipoprotein particle clearance (GO:0034383) | 2.70485412 |
| 123 | mannose metabolic process (GO:0006013) | 2.70402701 |
| 124 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.70174681 |
| 125 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.70062179 |
| 126 | oxidative phosphorylation (GO:0006119) | 2.70015288 |
| 127 | regulation of the force of heart contraction (GO:0002026) | 2.69419171 |
| 128 | alpha-linolenic acid metabolic process (GO:0036109) | 2.69188026 |
| 129 | adult heart development (GO:0007512) | 2.68840109 |
| 130 | actin filament-based movement (GO:0030048) | 2.68779368 |
| 131 | activation of Rac GTPase activity (GO:0032863) | 2.68589154 |
| 132 | glucan catabolic process (GO:0009251) | 2.68163888 |
| 133 | negative regulation of cell size (GO:0045792) | 2.67933101 |
| 134 | adherens junction assembly (GO:0034333) | 2.65402387 |
| 135 | cellular modified amino acid catabolic process (GO:0042219) | 2.64895175 |
| 136 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.64014769 |
| 137 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.63978202 |
| 138 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.62070450 |
| 139 | glycolipid catabolic process (GO:0019377) | 2.59969294 |
| 140 | embryonic process involved in female pregnancy (GO:0060136) | 2.57428700 |
| 141 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.56984894 |
| 142 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.56984894 |
| 143 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.55576217 |
| 144 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.55295603 |
| 145 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.54918115 |
| 146 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.54122654 |
| 147 | cell-substrate junction assembly (GO:0007044) | 2.53864499 |
| 148 | maternal placenta development (GO:0001893) | 2.49935167 |
| 149 | proline metabolic process (GO:0006560) | 2.49392885 |
| 150 | muscle atrophy (GO:0014889) | 2.49179479 |
| 151 | cellular polysaccharide catabolic process (GO:0044247) | 2.47801795 |
| 152 | negative regulation of myotube differentiation (GO:0010832) | 2.45348407 |
| 153 | GDP-mannose metabolic process (GO:0019673) | 2.44053830 |
| 154 | glycogen catabolic process (GO:0005980) | 2.43697534 |
| 155 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.42911563 |
| 156 | regulation of pseudopodium assembly (GO:0031272) | 2.42259603 |
| 157 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.40362000 |
| 158 | pentose-phosphate shunt (GO:0006098) | 2.38684850 |
| 159 | epoxygenase P450 pathway (GO:0019373) | 2.35481130 |
| 160 | glucose catabolic process (GO:0006007) | 2.34834847 |
| 161 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.34092500 |
| 162 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.33273910 |
| 163 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.32300144 |
| 164 | striated muscle adaptation (GO:0014888) | 2.31779569 |
| 165 | positive regulation of receptor recycling (GO:0001921) | 2.30648324 |
| 166 | regulation of cholesterol metabolic process (GO:0090181) | 2.28613033 |
| 167 | negative regulation of fatty acid transport (GO:2000192) | 2.27893232 |
| 168 | response to laminar fluid shear stress (GO:0034616) | 2.26258168 |
| 169 | protein-lipid complex assembly (GO:0065005) | 2.25434831 |
| 170 | modulation by symbiont of host cellular process (GO:0044068) | 2.24166267 |
| 171 | diacylglycerol metabolic process (GO:0046339) | 2.22340100 |
| 172 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.21194277 |
| 173 | negative regulation of necrotic cell death (GO:0060547) | 2.21144108 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.12897251 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.08423160 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.64707600 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.62398210 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.12051610 |
| 6 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.07686808 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.06638579 |
| 8 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.63016229 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.58618551 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.46649999 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.44024037 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.31395677 |
| 13 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.23244373 |
| 14 | * MYC_22102868_ChIP-Seq_BL_Human | 2.17028581 |
| 15 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.07652211 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.04600445 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.00308216 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.94132728 |
| 19 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.91948666 |
| 20 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.91948666 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.78347029 |
| 22 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.73041453 |
| 23 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.71702919 |
| 24 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.68079186 |
| 25 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.61715795 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.59730210 |
| 27 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.56700794 |
| 28 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.53215245 |
| 29 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.52850353 |
| 30 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.51537502 |
| 31 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.48910580 |
| 32 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.46755465 |
| 33 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.45375022 |
| 34 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.44928770 |
| 35 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.44339593 |
| 36 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.43876927 |
| 37 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.42175362 |
| 38 | ATF3_27146783_Chip-Seq_COLON_Human | 1.41703444 |
| 39 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.40162601 |
| 40 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.39437529 |
| 41 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.37357896 |
| 42 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.35235769 |
| 43 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33642749 |
| 44 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.32022023 |
| 45 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.32017613 |
| 46 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.28643322 |
| 47 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.28114346 |
| 48 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.26561090 |
| 49 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.26466703 |
| 50 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.24810034 |
| 51 | P68_20966046_ChIP-Seq_HELA_Human | 1.24018202 |
| 52 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.23687021 |
| 53 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.22268400 |
| 54 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.22096323 |
| 55 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.20450765 |
| 56 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.19599397 |
| 57 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.18002812 |
| 58 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.17981305 |
| 59 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.17689156 |
| 60 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.17537567 |
| 61 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17122467 |
| 62 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.16867217 |
| 63 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.16822109 |
| 64 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.16733617 |
| 65 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.15274231 |
| 66 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.15244147 |
| 67 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.14981031 |
| 68 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.13160754 |
| 69 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.12895635 |
| 70 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.12740957 |
| 71 | KDM2B_26808549_Chip-Seq_K562_Human | 1.12641395 |
| 72 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.12592293 |
| 73 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.12296217 |
| 74 | MAF_26560356_Chip-Seq_TH2_Human | 1.12273450 |
| 75 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.11766910 |
| 76 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.10941215 |
| 77 | * PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.10449000 |
| 78 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.10232877 |
| 79 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.10079282 |
| 80 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.09935998 |
| 81 | GATA1_19941826_ChIP-Seq_K562_Human | 1.09408396 |
| 82 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.08263911 |
| 83 | UTX_26944678_Chip-Seq_JUKART_Human | 1.07769220 |
| 84 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07694941 |
| 85 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07619926 |
| 86 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.07227211 |
| 87 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.06062211 |
| 88 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.05917877 |
| 89 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.05547908 |
| 90 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.05485574 |
| 91 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05015630 |
| 92 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.04209060 |
| 93 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.04016697 |
| 94 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03196862 |
| 95 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.02743454 |
| 96 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.02496319 |
| 97 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.02388056 |
| 98 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.02339742 |
| 99 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.02324846 |
| 100 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.02270153 |
| 101 | GATA2_19941826_ChIP-Seq_K562_Human | 1.01566205 |
| 102 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.01185030 |
| 103 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.01176406 |
| 104 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.00301018 |
| 105 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.99894737 |
| 106 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.98989726 |
| 107 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.98547948 |
| 108 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97723546 |
| 109 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.96955339 |
| 110 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.94997926 |
| 111 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.94989820 |
| 112 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.94395718 |
| 113 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.93704983 |
| 114 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91717655 |
| 115 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.90924295 |
| 116 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.90722056 |
| 117 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.89751378 |
| 118 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.89207036 |
| 119 | MAF_26560356_Chip-Seq_TH1_Human | 0.87550120 |
| 120 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.87012861 |
| 121 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.86634705 |
| 122 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.86499518 |
| 123 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.86460311 |
| 124 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.86227850 |
| 125 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.85309710 |
| 126 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.84969220 |
| 127 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.84698452 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 4.66524254 |
| 2 | MP0003646_muscle_fatigue | 4.34709625 |
| 3 | MP0005360_urolithiasis | 4.33195234 |
| 4 | MP0000751_myopathy | 3.57089245 |
| 5 | MP0004084_abnormal_cardiac_muscle | 3.46789612 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 2.91732448 |
| 7 | MP0004130_abnormal_muscle_cell | 2.83628593 |
| 8 | MP0005330_cardiomyopathy | 2.78197140 |
| 9 | MP0004215_abnormal_myocardial_fiber | 2.77976282 |
| 10 | MP0004036_abnormal_muscle_relaxation | 2.70778013 |
| 11 | MP0000749_muscle_degeneration | 2.57345465 |
| 12 | MP0005085_abnormal_gallbladder_physiolo | 2.55558237 |
| 13 | MP0009840_abnormal_foam_cell | 2.52417165 |
| 14 | MP0003705_abnormal_hypodermis_morpholog | 2.42828125 |
| 15 | MP0004087_abnormal_muscle_fiber | 2.31425182 |
| 16 | MP0005365_abnormal_bile_salt | 2.09434051 |
| 17 | MP0002972_abnormal_cardiac_muscle | 2.05010817 |
| 18 | MP0003252_abnormal_bile_duct | 1.99736986 |
| 19 | MP0004043_abnormal_pH_regulation | 1.97633538 |
| 20 | MP0008260_abnormal_autophagy | 1.97068324 |
| 21 | MP0000750_abnormal_muscle_regeneration | 1.92505718 |
| 22 | MP0005332_abnormal_amino_acid | 1.89113402 |
| 23 | MP0008775_abnormal_heart_ventricle | 1.86457960 |
| 24 | MP0005620_abnormal_muscle_contractility | 1.85226399 |
| 25 | MP0008875_abnormal_xenobiotic_pharmacok | 1.83195669 |
| 26 | MP0004264_abnormal_extraembryonic_tissu | 1.81223426 |
| 27 | MP0010630_abnormal_cardiac_muscle | 1.80335526 |
| 28 | MP0001666_abnormal_nutrient_absorption | 1.78804733 |
| 29 | MP0001544_abnormal_cardiovascular_syste | 1.78206210 |
| 30 | MP0005385_cardiovascular_system_phenoty | 1.78206210 |
| 31 | MP0010329_abnormal_lipoprotein_level | 1.77903679 |
| 32 | MP0000747_muscle_weakness | 1.76021247 |
| 33 | MP0002269_muscular_atrophy | 1.75860364 |
| 34 | MP0005670_abnormal_white_adipose | 1.74904812 |
| 35 | * MP0005666_abnormal_adipose_tissue | 1.74247684 |
| 36 | MP0003137_abnormal_impulse_conducting | 1.72351483 |
| 37 | MP0004185_abnormal_adipocyte_glucose | 1.71503517 |
| 38 | MP0006036_abnormal_mitochondrial_physio | 1.68192280 |
| 39 | MP0002106_abnormal_muscle_physiology | 1.67161812 |
| 40 | MP0004484_altered_response_of | 1.66581382 |
| 41 | MP0005409_darkened_coat_color | 1.66544798 |
| 42 | MP0003453_abnormal_keratinocyte_physiol | 1.66338723 |
| 43 | MP0003191_abnormal_cellular_cholesterol | 1.64456131 |
| 44 | MP0010234_abnormal_vibrissa_follicle | 1.64280479 |
| 45 | MP0003436_decreased_susceptibility_to | 1.60979377 |
| 46 | MP0006138_congestive_heart_failure | 1.57324447 |
| 47 | * MP0005451_abnormal_body_composition | 1.56487556 |
| 48 | MP0001849_ear_inflammation | 1.55886056 |
| 49 | MP0003806_abnormal_nucleotide_metabolis | 1.49940271 |
| 50 | MP0003221_abnormal_cardiomyocyte_apopto | 1.46936538 |
| 51 | MP0010155_abnormal_intestine_physiology | 1.46481908 |
| 52 | MP0004510_myositis | 1.42414901 |
| 53 | MP0009643_abnormal_urine_homeostasis | 1.41967310 |
| 54 | MP0003183_abnormal_peptide_metabolism | 1.41738604 |
| 55 | MP0000678_abnormal_parathyroid_gland | 1.41232284 |
| 56 | MP0000759_abnormal_skeletal_muscle | 1.38574426 |
| 57 | MP0005319_abnormal_enzyme/_coenzyme | 1.37446462 |
| 58 | MP0004947_skin_inflammation | 1.35654527 |
| 59 | MP0005083_abnormal_biliary_tract | 1.34327565 |
| 60 | MP0005076_abnormal_cell_differentiation | 1.32354440 |
| 61 | MP0003828_pulmonary_edema | 1.31506025 |
| 62 | * MP0002118_abnormal_lipid_homeostasis | 1.31480624 |
| 63 | MP0003195_calcinosis | 1.29749124 |
| 64 | MP0001873_stomach_inflammation | 1.29273559 |
| 65 | MP0004145_abnormal_muscle_electrophysio | 1.26580345 |
| 66 | MP0008961_abnormal_basal_metabolism | 1.25172013 |
| 67 | MP0005369_muscle_phenotype | 1.24466407 |
| 68 | MP0004019_abnormal_vitamin_homeostasis | 1.24032344 |
| 69 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.19540049 |
| 70 | MP0002971_abnormal_brown_adipose | 1.19271536 |
| 71 | MP0005501_abnormal_skin_physiology | 1.17666011 |
| 72 | * MP0005375_adipose_tissue_phenotype | 1.16586414 |
| 73 | MP0002877_abnormal_melanocyte_morpholog | 1.15993433 |
| 74 | MP0000609_abnormal_liver_physiology | 1.13932285 |
| 75 | MP0002332_abnormal_exercise_endurance | 1.13787813 |
| 76 | MP0005167_abnormal_blood-brain_barrier | 1.13591545 |
| 77 | MP0000733_abnormal_muscle_development | 1.13159374 |
| 78 | MP0004085_abnormal_heartbeat | 1.12432288 |
| 79 | MP0003300_gastrointestinal_ulcer | 1.11468009 |
| 80 | MP0005058_abnormal_lysosome_morphology | 1.09700811 |
| 81 | MP0000858_altered_metastatic_potential | 1.06558056 |
| 82 | MP0003566_abnormal_cell_adhesion | 1.04531188 |
| 83 | MP0004233_abnormal_muscle_weight | 1.04377898 |
| 84 | MP0003879_abnormal_hair_cell | 1.02999184 |
| 85 | MP0000343_altered_response_to | 1.02925846 |
| 86 | MP0000490_abnormal_crypts_of | 1.02741810 |
| 87 | MP0002822_catalepsy | 1.02696402 |
| 88 | MP0001765_abnormal_ion_homeostasis | 1.02287450 |
| 89 | MP0009333_abnormal_splenocyte_physiolog | 1.00635902 |
| 90 | MP0001756_abnormal_urination | 0.99894454 |
| 91 | MP0002909_abnormal_adrenal_gland | 0.96706951 |
| 92 | MP0005025_abnormal_response_to | 0.96017122 |
| 93 | MP0005165_increased_susceptibility_to | 0.90468942 |
| 94 | MP0000230_abnormal_systemic_arterial | 0.89909849 |
| 95 | MP0006035_abnormal_mitochondrial_morpho | 0.87798425 |
| 96 | MP0005535_abnormal_body_temperature | 0.87642672 |
| 97 | MP0005266_abnormal_metabolism | 0.87424879 |
| 98 | MP0002419_abnormal_innate_immunity | 0.84682603 |
| 99 | MP0002078_abnormal_glucose_homeostasis | 0.84576297 |
| 100 | MP0004782_abnormal_surfactant_physiolog | 0.83314327 |
| 101 | MP0000685_abnormal_immune_system | 0.82177789 |
| 102 | MP0003091_abnormal_cell_migration | 0.80424764 |
| 103 | MP0001216_abnormal_epidermal_layer | 0.79111257 |
| 104 | MP0009278_abnormal_bone_marrow | 0.76961522 |
| 105 | MP0000467_abnormal_esophagus_morphology | 0.76872468 |
| 106 | MP0002136_abnormal_kidney_physiology | 0.76551583 |
| 107 | MP0000477_abnormal_intestine_morphology | 0.76132300 |
| 108 | MP0002796_impaired_skin_barrier | 0.75937211 |
| 109 | MP0002138_abnormal_hepatobiliary_system | 0.75806934 |
| 110 | MP0003283_abnormal_digestive_organ | 0.75585928 |
| 111 | MP0003075_altered_response_to | 0.74647743 |
| 112 | MP0001533_abnormal_skeleton_physiology | 0.74351971 |
| 113 | MP0005464_abnormal_platelet_physiology | 0.74290518 |
| 114 | MP0003172_abnormal_lysosome_physiology | 0.73329386 |
| 115 | MP0001661_extended_life_span | 0.72882146 |
| 116 | MP0005023_abnormal_wound_healing | 0.72732255 |
| 117 | MP0000003_abnormal_adipose_tissue | 0.70774928 |
| 118 | MP0005166_decreased_susceptibility_to | 0.68771820 |
| 119 | MP0003303_peritoneal_inflammation | 0.68576761 |
| 120 | MP0005636_abnormal_mineral_homeostasis | 0.67666282 |
| 121 | MP0000013_abnormal_adipose_tissue | 0.67575741 |
| 122 | * MP0005334_abnormal_fat_pad | 0.64206197 |
| 123 | MP0000266_abnormal_heart_morphology | 0.63023255 |
| 124 | MP0002234_abnormal_pharynx_morphology | 0.61881301 |
| 125 | MP0009780_abnormal_chondrocyte_physiolo | 0.60255621 |
| 126 | MP0004858_abnormal_nervous_system | 0.59769637 |
| 127 | MP0000604_amyloidosis | 0.59527373 |
| 128 | MP0003329_amyloid_beta_deposits | 0.59320466 |
| 129 | MP0003045_fibrosis | 0.57415373 |
| 130 | MP0009642_abnormal_blood_homeostasis | 0.56907299 |
| 131 | MP0010352_gastrointestinal_tract_polyps | 0.55664431 |
| 132 | MP0002127_abnormal_cardiovascular_syste | 0.55310668 |
| 133 | * MP0005448_abnormal_energy_balance | 0.54525448 |
| 134 | MP0003866_abnormal_defecation | 0.52122890 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 5.28877169 |
| 2 | Nemaline bodies (HP:0003798) | 4.73712221 |
| 3 | Exercise-induced myalgia (HP:0003738) | 4.65240412 |
| 4 | Exercise-induced muscle cramps (HP:0003710) | 4.59890449 |
| 5 | Ventricular tachycardia (HP:0004756) | 4.57701022 |
| 6 | Myoglobinuria (HP:0002913) | 4.54306825 |
| 7 | Right ventricular cardiomyopathy (HP:0011663) | 4.41312696 |
| 8 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.18324001 |
| 9 | Myopathic facies (HP:0002058) | 4.16328669 |
| 10 | Muscle fiber splitting (HP:0003555) | 4.07206571 |
| 11 | Distal lower limb amyotrophy (HP:0008944) | 3.89002114 |
| 12 | Calf muscle hypertrophy (HP:0008981) | 3.84597742 |
| 13 | Hyperglycinuria (HP:0003108) | 3.73977337 |
| 14 | Hyporeflexia of lower limbs (HP:0002600) | 3.72342928 |
| 15 | Bundle branch block (HP:0011710) | 3.63865158 |
| 16 | Rhabdomyolysis (HP:0003201) | 3.58028338 |
| 17 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.56878965 |
| 18 | Ketoacidosis (HP:0001993) | 3.48498984 |
| 19 | Increased connective tissue (HP:0009025) | 3.46878688 |
| 20 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.44847606 |
| 21 | Palpitations (HP:0001962) | 3.44341918 |
| 22 | Asymmetric septal hypertrophy (HP:0001670) | 3.40628856 |
| 23 | Hypoglycemic coma (HP:0001325) | 3.39729993 |
| 24 | Lipoatrophy (HP:0100578) | 3.31517419 |
| 25 | Syncope (HP:0001279) | 3.28467666 |
| 26 | Atrial fibrillation (HP:0005110) | 3.27442772 |
| 27 | Ketosis (HP:0001946) | 3.25140210 |
| 28 | Abnormality of the calf musculature (HP:0001430) | 3.20104136 |
| 29 | Difficulty running (HP:0009046) | 3.16224010 |
| 30 | Dicarboxylic aciduria (HP:0003215) | 3.11277449 |
| 31 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.11277449 |
| 32 | Subaortic stenosis (HP:0001682) | 3.06525051 |
| 33 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.06525051 |
| 34 | Hyperammonemia (HP:0001987) | 3.05732287 |
| 35 | Primary atrial arrhythmia (HP:0001692) | 3.05257422 |
| 36 | Abnormality of glycine metabolism (HP:0010895) | 3.04691931 |
| 37 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.04691931 |
| 38 | Ventricular arrhythmia (HP:0004308) | 2.99108049 |
| 39 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.98477182 |
| 40 | EMG: myopathic abnormalities (HP:0003458) | 2.96701482 |
| 41 | Heart block (HP:0012722) | 2.96464557 |
| 42 | Ventricular fibrillation (HP:0001663) | 2.96418816 |
| 43 | Gout (HP:0001997) | 2.96027386 |
| 44 | Dilated cardiomyopathy (HP:0001644) | 2.95186959 |
| 45 | Supraventricular tachycardia (HP:0004755) | 2.93409509 |
| 46 | Supraventricular arrhythmia (HP:0005115) | 2.91276854 |
| 47 | Atrioventricular block (HP:0001678) | 2.86649700 |
| 48 | Abnormal atrioventricular conduction (HP:0005150) | 2.86375233 |
| 49 | Bulbar palsy (HP:0001283) | 2.82540154 |
| 50 | Prolonged QT interval (HP:0001657) | 2.76447490 |
| 51 | Xanthomatosis (HP:0000991) | 2.69196448 |
| 52 | Eczematoid dermatitis (HP:0000976) | 2.62618626 |
| 53 | Conjunctival hamartoma (HP:0100780) | 2.58216516 |
| 54 | Lower limb amyotrophy (HP:0007210) | 2.55680597 |
| 55 | Round ear (HP:0100830) | 2.54296470 |
| 56 | Muscle stiffness (HP:0003552) | 2.53321291 |
| 57 | Difficulty climbing stairs (HP:0003551) | 2.53181858 |
| 58 | Myotonia (HP:0002486) | 2.47273443 |
| 59 | Abnormality of purine metabolism (HP:0004352) | 2.46836458 |
| 60 | Hydroxyprolinuria (HP:0003080) | 2.42595255 |
| 61 | Abnormality of proline metabolism (HP:0010907) | 2.42595255 |
| 62 | Generalized aminoaciduria (HP:0002909) | 2.41725085 |
| 63 | Achilles tendon contracture (HP:0001771) | 2.40448993 |
| 64 | Hyperuricemia (HP:0002149) | 2.38926223 |
| 65 | Increased purine levels (HP:0004368) | 2.38926223 |
| 66 | Hemorrhage of the eye (HP:0011885) | 2.37834225 |
| 67 | Type 1 muscle fiber predominance (HP:0003803) | 2.37212433 |
| 68 | Increased muscle lipid content (HP:0009058) | 2.34647734 |
| 69 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.30915329 |
| 70 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.30112956 |
| 71 | Ulnar deviation of the wrist (HP:0003049) | 2.27803044 |
| 72 | Proximal tubulopathy (HP:0000114) | 2.25796614 |
| 73 | Progressive muscle weakness (HP:0003323) | 2.24227821 |
| 74 | Foot dorsiflexor weakness (HP:0009027) | 2.21677911 |
| 75 | Dysmetric saccades (HP:0000641) | 2.20384633 |
| 76 | Hypoalphalipoproteinemia (HP:0003233) | 2.18904396 |
| 77 | Nausea (HP:0002018) | 2.17204629 |
| 78 | Systemic lupus erythematosus (HP:0002725) | 2.13528643 |
| 79 | Muscle fiber inclusion bodies (HP:0100299) | 2.12562499 |
| 80 | Metabolic acidosis (HP:0001942) | 2.11878817 |
| 81 | Hamartoma of the eye (HP:0010568) | 2.11716535 |
| 82 | Hepatic necrosis (HP:0002605) | 2.11375693 |
| 83 | Flat acetabular roof (HP:0003180) | 2.11238557 |
| 84 | Hyperglycinemia (HP:0002154) | 2.09422811 |
| 85 | Abnormality of the foot musculature (HP:0001436) | 2.08994098 |
| 86 | Thin bony cortex (HP:0002753) | 2.07642441 |
| 87 | Increased variability in muscle fiber diameter (HP:0003557) | 2.07384215 |
| 88 | Cerebral edema (HP:0002181) | 2.04780872 |
| 89 | Late onset (HP:0003584) | 2.04332939 |
| 90 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.04095623 |
| 91 | Distal arthrogryposis (HP:0005684) | 2.04017881 |
| 92 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.02257729 |
| 93 | Axonal loss (HP:0003447) | 2.01247000 |
| 94 | Distal lower limb muscle weakness (HP:0009053) | 2.00932530 |
| 95 | Abnormal EKG (HP:0003115) | 1.98636280 |
| 96 | Ragged-red muscle fibers (HP:0003200) | 1.98227053 |
| 97 | Distal upper limb amyotrophy (HP:0007149) | 1.97616062 |
| 98 | Upper limb amyotrophy (HP:0009129) | 1.97616062 |
| 99 | Metabolic alkalosis (HP:0200114) | 1.97094604 |
| 100 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.93675137 |
| 101 | Cholelithiasis (HP:0001081) | 1.93088856 |
| 102 | Neoplasm of head and neck (HP:0012288) | 1.90241871 |
| 103 | Esophageal neoplasm (HP:0100751) | 1.90241871 |
| 104 | Stridor (HP:0010307) | 1.89547451 |
| 105 | Limb-girdle muscle atrophy (HP:0003797) | 1.89495572 |
| 106 | Ileus (HP:0002595) | 1.89267221 |
| 107 | Malnutrition (HP:0004395) | 1.89172646 |
| 108 | Easy fatigability (HP:0003388) | 1.88949861 |
| 109 | Lymphangioma (HP:0100764) | 1.88820389 |
| 110 | Lethargy (HP:0001254) | 1.88171100 |
| 111 | Facial diplegia (HP:0001349) | 1.87960161 |
| 112 | Vomiting (HP:0002013) | 1.87439499 |
| 113 | EMG: neuropathic changes (HP:0003445) | 1.84638135 |
| 114 | Frequent falls (HP:0002359) | 1.84456017 |
| 115 | Hypolipoproteinemia (HP:0010981) | 1.82071110 |
| 116 | Polycythemia (HP:0001901) | 1.81887324 |
| 117 | Abnormality of complement system (HP:0005339) | 1.81823335 |
| 118 | Testicular atrophy (HP:0000029) | 1.80909605 |
| 119 | Multiple enchondromatosis (HP:0005701) | 1.80336699 |
| 120 | Hyperactive renin-angiotensin system (HP:0000841) | 1.79806766 |
| 121 | Deep venous thrombosis (HP:0002625) | 1.79775480 |
| 122 | Vertebral compression fractures (HP:0002953) | 1.79360778 |
| 123 | Acute encephalopathy (HP:0006846) | 1.77833421 |
| 124 | Abnormality of the Achilles tendon (HP:0005109) | 1.77666559 |
| 125 | Neck muscle weakness (HP:0000467) | 1.77499297 |
| 126 | Generalized muscle weakness (HP:0003324) | 1.77356919 |
| 127 | Cerebral aneurysm (HP:0004944) | 1.77077534 |
| 128 | Spinal rigidity (HP:0003306) | 1.77023625 |
| 129 | Scapular winging (HP:0003691) | 1.76403489 |
| 130 | Diaphragmatic weakness (HP:0009113) | 1.74206265 |
| 131 | Colitis (HP:0002583) | 1.72985313 |
| 132 | Hyperparathyroidism (HP:0000843) | 1.68969282 |
| 133 | Cellulitis (HP:0100658) | 1.65576112 |
| 134 | Abdominal distention (HP:0003270) | 1.64887740 |
| 135 | Gingivitis (HP:0000230) | 1.62876577 |
| 136 | Abnormality of macrophages (HP:0004311) | 1.62647129 |
| 137 | Abnormal gallbladder physiology (HP:0012438) | 1.59794723 |
| 138 | Cholecystitis (HP:0001082) | 1.59794723 |
| 139 | Generalized amyotrophy (HP:0003700) | 1.59152356 |
| 140 | Hyperacusis (HP:0010780) | 1.58500559 |
| 141 | Increased serum ferritin (HP:0003281) | 1.57804165 |
| 142 | Rimmed vacuoles (HP:0003805) | 1.57711184 |
| 143 | Fatigue (HP:0012378) | 1.57440133 |
| 144 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.53331070 |
| 145 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.51413840 |
| 146 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.51413840 |
| 147 | Abnormality of glycolipid metabolism (HP:0010969) | 1.51413840 |
| 148 | Growth hormone excess (HP:0000845) | 1.51157117 |
| 149 | Glomerulonephritis (HP:0000099) | 1.50459023 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.42155598 |
| 2 | TTN | 4.34369601 |
| 3 | PKN2 | 3.36281543 |
| 4 | LMTK2 | 3.23908169 |
| 5 | BCKDK | 3.05827577 |
| 6 | PRPF4B | 2.91989810 |
| 7 | EPHA2 | 2.76227812 |
| 8 | IRAK3 | 2.74662406 |
| 9 | SMG1 | 2.62502520 |
| 10 | PDK4 | 2.53600740 |
| 11 | PDK3 | 2.53600740 |
| 12 | PHKG1 | 2.44350410 |
| 13 | PHKG2 | 2.44350410 |
| 14 | OBSCN | 2.34753671 |
| 15 | DMPK | 2.09686423 |
| 16 | RIPK1 | 2.05472698 |
| 17 | ERN1 | 2.02962103 |
| 18 | NEK1 | 1.88023129 |
| 19 | MYLK | 1.84683714 |
| 20 | PTK6 | 1.63552732 |
| 21 | MAP3K7 | 1.62640458 |
| 22 | WNK4 | 1.51580380 |
| 23 | PDK2 | 1.49984753 |
| 24 | MST1R | 1.48205089 |
| 25 | PINK1 | 1.46192548 |
| 26 | ARAF | 1.36923952 |
| 27 | TAOK2 | 1.34890648 |
| 28 | SIK1 | 1.32872672 |
| 29 | MAP3K13 | 1.30000045 |
| 30 | EEF2K | 1.28079269 |
| 31 | PIK3CA | 1.22887311 |
| 32 | MAP3K10 | 1.22115516 |
| 33 | TAOK1 | 1.21915483 |
| 34 | RIPK4 | 1.20980253 |
| 35 | FGFR4 | 1.16791865 |
| 36 | MAPKAPK3 | 1.16648728 |
| 37 | TESK1 | 1.10198215 |
| 38 | IRAK4 | 1.10059908 |
| 39 | TESK2 | 1.07138186 |
| 40 | MAP2K3 | 1.06282189 |
| 41 | STK38 | 1.05451315 |
| 42 | KSR2 | 1.01313912 |
| 43 | FRK | 0.99808309 |
| 44 | PRKAA2 | 0.99593441 |
| 45 | PRKG2 | 0.98465607 |
| 46 | IRAK2 | 0.97289288 |
| 47 | PRKD1 | 0.92222216 |
| 48 | EPHB1 | 0.91879175 |
| 49 | PRKAA1 | 0.90352346 |
| 50 | LRRK2 | 0.90125575 |
| 51 | PDPK1 | 0.89194063 |
| 52 | PRKD2 | 0.89100362 |
| 53 | MAP3K3 | 0.88995063 |
| 54 | ICK | 0.88411259 |
| 55 | PDGFRA | 0.86018791 |
| 56 | ZAP70 | 0.84737966 |
| 57 | TYK2 | 0.83143739 |
| 58 | PIM2 | 0.82790490 |
| 59 | ILK | 0.82761282 |
| 60 | GRK6 | 0.81973106 |
| 61 | PAK3 | 0.81634318 |
| 62 | BMX | 0.80420450 |
| 63 | MARK2 | 0.79168120 |
| 64 | DAPK3 | 0.77737434 |
| 65 | MET | 0.77327698 |
| 66 | PDK1 | 0.76071551 |
| 67 | TBK1 | 0.75975180 |
| 68 | MAPK11 | 0.75430382 |
| 69 | EPHB2 | 0.75303630 |
| 70 | MAPK12 | 0.74880511 |
| 71 | STK24 | 0.74833915 |
| 72 | MAP3K11 | 0.72936249 |
| 73 | PRKD3 | 0.72014912 |
| 74 | MUSK | 0.71993842 |
| 75 | WNK3 | 0.69966985 |
| 76 | RPS6KA2 | 0.69063760 |
| 77 | MAP4K1 | 0.68495338 |
| 78 | MAP3K5 | 0.68436981 |
| 79 | MAP3K6 | 0.68093230 |
| 80 | MAP3K14 | 0.67396861 |
| 81 | JAK1 | 0.66716125 |
| 82 | MTOR | 0.65553006 |
| 83 | LATS2 | 0.64959441 |
| 84 | TIE1 | 0.64482522 |
| 85 | BRAF | 0.64148643 |
| 86 | TGFBR2 | 0.63748969 |
| 87 | NME1 | 0.62423973 |
| 88 | CDK12 | 0.61844751 |
| 89 | MAP2K2 | 0.60592089 |
| 90 | RPS6KB2 | 0.59437160 |
| 91 | CDC42BPA | 0.58001824 |
| 92 | ROCK1 | 0.57661411 |
| 93 | JAK2 | 0.57156566 |
| 94 | MAP3K8 | 0.56437108 |
| 95 | MAP2K1 | 0.55125746 |
| 96 | MAP3K1 | 0.54620514 |
| 97 | PTK2 | 0.53548251 |
| 98 | CAMK2D | 0.52690061 |
| 99 | SGK3 | 0.52045907 |
| 100 | BLK | 0.51416925 |
| 101 | MAP3K9 | 0.50823867 |
| 102 | TNK2 | 0.49479061 |
| 103 | MAP2K6 | 0.48532349 |
| 104 | CAMK1D | 0.48523024 |
| 105 | CAMKK1 | 0.47977886 |
| 106 | RET | 0.47556774 |
| 107 | CAMK4 | 0.46973878 |
| 108 | CAMK2G | 0.46197794 |
| 109 | TAOK3 | 0.46037750 |
| 110 | PRKCH | 0.45628456 |
| 111 | FLT3 | 0.44442472 |
| 112 | RPS6KA6 | 0.43847208 |
| 113 | PRKACG | 0.43666485 |
| 114 | NME2 | 0.43326061 |
| 115 | STK38L | 0.43206898 |
| 116 | SCYL2 | 0.42964237 |
| 117 | TRPM7 | 0.42097034 |
| 118 | MAP2K4 | 0.41891380 |
| 119 | ABL2 | 0.41798411 |
| 120 | MOS | 0.41236672 |
| 121 | DYRK1B | 0.41028545 |
| 122 | NEK9 | 0.40790713 |
| 123 | WNK1 | 0.40585691 |
| 124 | MAP3K2 | 0.39533480 |
| 125 | STK11 | 0.39149068 |
| 126 | PIK3CG | 0.37618335 |
| 127 | PAK6 | 0.37548793 |
| 128 | KDR | 0.37160144 |
| 129 | DDR2 | 0.36915061 |
| 130 | CSK | 0.36554981 |
| 131 | AKT2 | 0.36035086 |
| 132 | DAPK2 | 0.36020081 |
| 133 | PAK4 | 0.35460263 |
| 134 | MAPK4 | 0.35390309 |
| 135 | FER | 0.34695145 |
| 136 | JAK3 | 0.33935456 |
| 137 | IRAK1 | 0.33146065 |
| 138 | RPS6KL1 | 0.33021187 |
| 139 | RPS6KC1 | 0.33021187 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.21315385 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.75380770 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.17017396 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.13112240 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.97216273 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.64448921 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.40621777 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.40359526 |
| 9 | Carbon metabolism_Homo sapiens_hsa01200 | 2.32913271 |
| 10 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.31654559 |
| 11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.16418173 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.10725116 |
| 13 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.06736891 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.03993453 |
| 15 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.82568160 |
| 16 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.81328707 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.79662259 |
| 18 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.71194502 |
| 19 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.69800906 |
| 20 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.68366259 |
| 21 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.61698860 |
| 22 | Bile secretion_Homo sapiens_hsa04976 | 1.50959194 |
| 23 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.49404135 |
| 24 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.43024836 |
| 25 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.42311693 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.37277357 |
| 27 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.34417321 |
| 28 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.30677853 |
| 29 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.29003297 |
| 30 | Peroxisome_Homo sapiens_hsa04146 | 1.25507576 |
| 31 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.24702892 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.19035952 |
| 33 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.16431176 |
| 34 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.15822880 |
| 35 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.14302700 |
| 36 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.11924254 |
| 37 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.08094568 |
| 38 | Galactose metabolism_Homo sapiens_hsa00052 | 1.06518502 |
| 39 | Bladder cancer_Homo sapiens_hsa05219 | 1.05100830 |
| 40 | Parkinsons disease_Homo sapiens_hsa05012 | 1.04984068 |
| 41 | Insulin resistance_Homo sapiens_hsa04931 | 1.03502783 |
| 42 | Prion diseases_Homo sapiens_hsa05020 | 1.03040585 |
| 43 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.03030463 |
| 44 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.00295483 |
| 45 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.99891026 |
| 46 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.98037304 |
| 47 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.97594121 |
| 48 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.97452577 |
| 49 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.96247718 |
| 50 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.93334137 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.92870728 |
| 52 | Hepatitis C_Homo sapiens_hsa05160 | 0.89992293 |
| 53 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.88534071 |
| 54 | Lysine degradation_Homo sapiens_hsa00310 | 0.86915533 |
| 55 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.86644783 |
| 56 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.86541830 |
| 57 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.85627594 |
| 58 | Leishmaniasis_Homo sapiens_hsa05140 | 0.84577125 |
| 59 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.82087868 |
| 60 | Alzheimers disease_Homo sapiens_hsa05010 | 0.80602419 |
| 61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.80362575 |
| 62 | Mineral absorption_Homo sapiens_hsa04978 | 0.77501967 |
| 63 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.76523170 |
| 64 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.75383343 |
| 65 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.73978877 |
| 66 | Thyroid cancer_Homo sapiens_hsa05216 | 0.73760994 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.73424610 |
| 68 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.73385773 |
| 69 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.73312431 |
| 70 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.72782043 |
| 71 | Sulfur relay system_Homo sapiens_hsa04122 | 0.72649324 |
| 72 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.71721384 |
| 73 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.71341713 |
| 74 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.70513330 |
| 75 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.70180725 |
| 76 | Endometrial cancer_Homo sapiens_hsa05213 | 0.69402565 |
| 77 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.68709458 |
| 78 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.68102726 |
| 79 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.66975208 |
| 80 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.64635733 |
| 81 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.63477931 |
| 82 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.63287147 |
| 83 | Tuberculosis_Homo sapiens_hsa05152 | 0.61711028 |
| 84 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.60327616 |
| 85 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.60102036 |
| 86 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60063309 |
| 87 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.60037644 |
| 88 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.60011643 |
| 89 | Lysosome_Homo sapiens_hsa04142 | 0.58545972 |
| 90 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.56576258 |
| 91 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.56220517 |
| 92 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.55757942 |
| 93 | Apoptosis_Homo sapiens_hsa04210 | 0.54982349 |
| 94 | ABC transporters_Homo sapiens_hsa02010 | 0.54624141 |
| 95 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.54319610 |
| 96 | Histidine metabolism_Homo sapiens_hsa00340 | 0.53436938 |
| 97 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.53179877 |
| 98 | Influenza A_Homo sapiens_hsa05164 | 0.52764675 |
| 99 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.52574299 |
| 100 | Viral myocarditis_Homo sapiens_hsa05416 | 0.50013606 |
| 101 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.49577916 |
| 102 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.49163899 |
| 103 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.48510395 |
| 104 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.48171535 |
| 105 | Salmonella infection_Homo sapiens_hsa05132 | 0.47926582 |
| 106 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47595131 |
| 107 | Pertussis_Homo sapiens_hsa05133 | 0.46832404 |
| 108 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.46397166 |
| 109 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.46091956 |
| 110 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.45923513 |
| 111 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.42984723 |
| 112 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.41824110 |
| 113 | Endocytosis_Homo sapiens_hsa04144 | 0.41051057 |
| 114 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.40969326 |
| 115 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.40344952 |
| 116 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.39390312 |
| 117 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.38808120 |
| 118 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.38793550 |
| 119 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.38210623 |
| 120 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.37614784 |
| 121 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.37253917 |
| 122 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.35633169 |
| 123 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34732527 |
| 124 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.34431770 |
| 125 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.33570885 |
| 126 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.33462942 |
| 127 | Huntingtons disease_Homo sapiens_hsa05016 | 0.33253289 |
| 128 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.29953044 |
| 129 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.29331975 |
| 130 | Amoebiasis_Homo sapiens_hsa05146 | 0.28915315 |
| 131 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26963400 |
| 132 | Focal adhesion_Homo sapiens_hsa04510 | 0.26536505 |
| 133 | Tight junction_Homo sapiens_hsa04530 | 0.22627859 |
| 134 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.22484670 |
| 135 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.22253494 |
| 136 | Metabolic pathways_Homo sapiens_hsa01100 | 0.21668323 |
| 137 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.21281720 |
| 138 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.20131671 |
| 139 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.16865150 |
| 140 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.16118966 |

